Search Results 2791-2800 of 17549 for pneumococcal vaccination

  1. Healthcare Delivery - 2022 Archives - Mayo Clinic News Network

    ... vaccine featured. Science Saturday: Uncovering disparities in local communities — the case of the HPV vaccine. Elizabeth Zimmermann. April 30, 2022. Immune ...

  2. Discovery Science - 2018 Archives - Mayo Clinic News Network

    A graduate student and a research group at Mayo Clinic have developed a new “Goldilocks” Ebola virus vaccine that could induce a “just right” immune[...].

  3. Publications - Michael C. Stephens, M.D. - Mayo Clinic

    Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).

  4. A Study to Evaluate the Effectiveness and Safety of PRV-015 in Adult Patients wth Non-responsive Celiac Disease as an Adjunct to a Gluten-free Diet - Mayo Clinic

    Administration of a live vaccine within 14 days prior to randomization and the first administration of study drug -History or presence of any clinically ...

  5. COPD - Doctors and departments - Mayo Clinic

    Depression, Arthritis, Urinary tract infection, COPD, Anxiety disorder, Pneumonia, Thyroid disease, Cellulitis, Metabolic disorders, Otitis, Hyperlipidemia, ...

  6. Publications - Scott H. Okuno, M.D. - Mayo Clinic

    Oncolytic Measles Virotherapy and Opposition to Measles Vaccination. Mayo Clin Proc. 2019 Sep; 94 (9):1834-1839 Epub 2019 June 22. View PubMed; Yolcu Y ...

  7. Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Subject has received an investigational drug (including investigational vaccines) or used an invasive investigational medical device within 4 weeks before ...

  8. A Study to Evaluate Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

    Subjects must not have received any live vaccine within 30 days of the first dose of investigational product. Treatment with any of the following therapies ...

  9. Effectiveness and Safety of Pembrolizumab for Participants with Resectable Stage IIB or IIIA Non-small Cell Lung Cancer - Mayo Clinic

    Has received a live vaccine within 30 days prior to the first dose of trial drug. Is currently participating in or has participated in a trial of an ...

  10. Infectious Diseases - 2020 Archives - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: COVID-19 vaccinations happening in phases featured image ... Hope arrives at Mayo Clinic locations as COVID-19 vaccinations begin ...